Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 2

Status

Completed 5Terminated 4Withdrawn 2Active not recruiting 2Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Genitourinary 1

Conditions

Stomach Neoplasms 2Small Cell Lung Carcinoma 1Carcinoma, Renal Cell 1

Interventions

Cyclophosphamide 166Docetaxel 154Bevacizumab 153Carboplatin 148Gemcitabine 146Cisplatin 146pembrolizumab 144Radiotherapy 135Paclitaxel 132Capecitabine 122Rituximab 115Oxaliplatin 104Fluorouracil 103Nivolumab 94Irinotecan 85Doxorubicin 85Pemetrexed 83Leucovorin 82Dexamethasone 82fludarabine 74fludarabine phosphate 72Bortezomib 69Etoposide 67Erlotinib Hydrochloride 66Cetuximab 65Methotrexate 58Trastuzumab 56Cytarabine 54Lenalidomide 50Everolimus 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Terminated × vistusertib × Clear all
NCT03061708 2019-05-20

AZD2014

Samsung Medical Center

Phase 2 Terminated
1 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03082833 2019-05-20

Phase II Trial of AZD2014 in TSC1/2 Mutated or TSC1/2 Null GC Patients as Second-line Chemotherapy

Samsung Medical Center

Phase 2 Terminated
1 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03106155 2018-09-20

[SUKSES-D]

Samsung Medical Center

Phase 2 Terminated
4 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT01793636 2014-06-24

ZEBRA

Queen Mary University of London

Phase 2 Terminated
49 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡